Transsexual Erections Page

This overview addresses the physiological aspects of erections for transgender individuals, specifically focusing on how gender-affirming hormone therapy (GAHT) and various surgical procedures influence erectile function. Hormonal Effects on Native Genitalia

For transgender men (AFAB) who undergo phalloplasty (the surgical creation of a phallus), the new genitalia do not contain erectile tissue (corpora cavernosa) and cannot become erect on their own. To achieve rigidity for penetrative intercourse, an is typically implanted after the initial phallus has healed:

For transgender women (AMAB) undergoing feminizing hormone therapy, the introduction of estrogen and the suppression of testosterone typically result in significant changes to erectile function: transsexual erections

: When erections do occur, they are often less rigid than before hormone therapy.

: A portion of the glans penis is often used to create a neo-clitoris. This tissue can still engorge with blood during arousal, providing a sensation similar to a natural clitoral erection. : A portion of the glans penis is

: The skin and tissue of the penis may become softer or thinner over time due to androgen deprivation.

: In some cases, a low-dose topical testosterone cream applied directly to the genitalia can help maintain tissue health and function without significantly affecting systemic hormone levels. : In some cases, a low-dose topical testosterone

: Some individuals utilize external sleeves or "erectile orthotics" if they choose not to undergo further surgery for an implant. Post-Surgical Sensations (Vaginoplasty)